Mechanisms and clinical consequences of critical illness associated adrenal insufficiency

Current Opinion in Critical Care

Volumn 13, Issue 4, 2007, Pages 363-369

  Marik, Paul E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adrenal; Adrenal insufficiency; Cortisol; Critical illness; Sepsis

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID RECEPTOR;

ADRENAL HEMORRHAGE; ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL FEATURE; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; GENERAL CONDITION IMPROVEMENT; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; REVIEW; SEPSIS; SEPTIC SHOCK; STRESS; SURVIVAL; TISSUE INJURY;

ADRENAL GLANDS; ADRENAL INSUFFICIENCY; CRITICAL ILLNESS; HUMANS; HYDROCORTISONE; PITUITARY-ADRENAL SYSTEM; UNITED STATES;

EID: 34347363214     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32818a6d74     Document Type: Review

References (98)

1. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 136:32.
2. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332:1351-1362.
3. Carrasco GA, Van de Kar LD, Carrasco GA, et al. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463:235-272.
4. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metab Clin Exp 2002; 51:5-10.
5. Behan DP, Grigoriadis DE, Lovenberg T, et al. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Mol Psychiatry 1996; 1:265-277.
6. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53:58-68.
7. Mueller UW, Potter JM. Binding of cortisol to human albumin and serum: the effect of protein concentration. Biochem Pharmacol 1981; 30:727-733.
8. Ho JT, Al-Musalhi H, Chapman MJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006; 91:105-114. This paper explores the changes in cortisol and CBG in patients with sepsis and septic shock.
9. Dimopoulou I, Alevizopoulou P, Dafni U, et al. Pituitary-adrenal response to human corticotropin-releasing hormone in critically ill patients. Intensive Care Med 2007; 33:454-459.
10. Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 2005; 34:293-313.
11. Borkowski AJ, Levin S, Delcroix C, et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. J Clin Invest 1967; 46:797-811.
12. Yaguchi H, Tsutsumi K, Shimono K, et al. Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. Life Sci 1998; 62:1387-1395.
13. Acton S, Rigotti A, Landschultz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
14. Calco D, Gomez-Coronado D, Lasuncion MA, et al. CLA-I is an 85-kD plasma membrane glycoprotein that acts as a high affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler Thromb Vasc Biol 1997; 17:2341-2349.
15. De la Llera-Moya M, Connelly MA, Drazul D, et al. Scavenger receptor class B type 1 affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res 2001; 42:1969-1978.
16. Liu J, Heikkila P, Meng QH, et al. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol 2000; 142:677-682.
17. Liu J, Voutilainen R, Heikkila P, et al. Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 1997; 82:2522-2527.
18. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361:1881-1893.
19. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005; 353:1711-1723.
20. Sinars CR, Cheung-Flynn J, Rimerman RA, et al. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci U S A 2003; 100:868-873.
21. Vermeer H, Hendriks-Stegeman BI, Van der Burg B, et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88:277-284.
22. Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16:61-71.
23. Limbourg FP, Huang Z, Plumier JC, et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 2002; 110:1729-1738.
24. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8:473-479.
25. Bobadilla NA, Tapia E, Jimenez F, et al. Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin. Am J Physiol 1999; 277:F464-F471.
26. Murata T, Hori M, Sakamoto K, et al. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am J Respir Crit Care Med 2004; 170:647-655.
27. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335:1206-1212.
28. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002; 122:1784-1796.
29. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88:385-389.
30. Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263:9067-9070.
31. Orlowski J, Lingrel JB. Thyroid and glucocorticoid hormones regulate the expression of multiple Na,K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem 1990; 265:3462-3470.
32. Auphan N, Didonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270:286-290.
33. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14:436-441.
34. Barnes PJ, Karin M. Nuclear factor-kB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071.
35. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145.
36. Marik PE, Kiminyo K, Zaloga GP. Adrenal insufficiency in critically ill HIV infected patients. Crit Care Med 2002; 30:1267-1273.
37. Kilger E, Weis F, Briegel J, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074.
38. Dimopoulou I, Tsagarakis S, Kouyialia AT, et al. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: Incidence, pathophysiology and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med 2004; 32:404-408.
39. Nacul FE, Jardim A, MacCord F, et al. Hemodynamic instability secondary to adrenal insufficiency in a major burn patient. Burns 2002; 28:270-272.
40. Sheridan RL, Ryan CM, Tompkins RG. Acute adrenal insufficiency in the burn intensive care unit. Burns 1993; 19:63-66.
41. Sibbald WJ, Short A, Cohen MP, et al. Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977; 186:29-33.
42. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60:947-952.
43. Briegel J, Scheelling G, Haller M, et al. A comparison of the adrenocorticcal response during septic shock and after complete recovery. Intensive Care Med 1996; 22:894-899.
44. Rivers EP, Gaspari M, Abi Saad G, et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001; 119:889-896.
45. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997; 42:27-31.
46. Beishuizen A, Vermes I, Hylkema BS, et al. Relative eosinophilia and functional adrenal insufficiency in critically ill patients [letter]. Lancet 1999; 353:1675-1676.
47. Drucker D, McLaughlin J. Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986; 14:789-791.
48. Drucker D, Shandling M. Variable adrenocortical function in acute medical illness. Crit Care Med 1985; 13:477-479.
49. Melby JC, Spink WW. Comparative studies of adrenal cortisal function and cortisol metabolism in healthy adults and in patients with septic shock due to infection. J Clin Invest 1958; 37:1791-1798.
50. Schein RM, Sprung CL, Marcial E. Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18:259-263.
51. Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271.
52. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871.
53. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17:25-42.
54. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045.
55. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326. This outstanding paper clearly establishes that CIRCI is a common complication in patients with severe sepsis and septic shock.
56. Bateman A, Singh A, Kral T, et al. The immune-hypothalamic- pituitary-adrenal axis. Endocr Rev 1989; 10:92-112.
57. Gaillard RC, Turnill D, Sappino P, et al. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127:101-106.
58. Richards ML, Caplan RH, Wickus GG, et al. The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery. Surgery 1999; 125:431-440.
59. Sharshar T, Gray F, De la Lorin GG, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003; 362:1799-1805.
60. Jaattela M, Ilvesmaki V, Voutilainen R, et al. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991; 128:623-629.
61. Natarajan R, Ploszay S, Horton R, et al. Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin II induced aldosterone synthesis. Endocrinology 1989; 125:3084-3089.
62. Jaattela M, Carpen O, Stenman UH, et al. Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-alpha. Mol Cell Endocrinol 1990; 68:R31-R36.
63. Sun X, Fischer DR, Pritts TA, et al. Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am J Physiol Regul Integr Comp Physiol 2002; 282:R509-R518.
64. Pariante CM, Pearce BD, Pisell TL, et al. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999; 140:4359-4366.
65. Liu DH, Su YP, Zhang W, et al. Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats. Crit Care Med 2002; 30:623-627.
66. Ali M, Allen HR, Vedeckis WV, et al. Depletion of rat liver glucocorticoid receptor hormone-binding and its mRNA in sepsis. LifeSci 1991; 48:603-611.
67. Krasznai A, Aranyi P, Feher T, et al. Alterations in the number of glucocorticoid receptors of circulating lymphocytes in sepsis. Haematologia 1986; 19:293-298.
68. Meduri GU, Muthiah MP, Carratu P, et al. Nuclear factor-kappaB- and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321-338.
69. Meduri GU, Tolley EA, Chrousos GP, et al. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165:983-991.
70. Goleva E, Ling-bo L, Eves PT, et al. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 2006; 173:607-616.
71. Scammell JG, Denny WB, Valentine DL, et al. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comp Endocrinol 2001; 124:152-165.
72. Alvarez C, Ramos A. Lipids, lipoproteins and apoproteins in serum during infection. Clin Chem 1986; 32:142-145.
73. Coombes EJ, Shakespeare PG, Batstone GF. Lipoprotein changes after burn injury in man. J Trauma 1980; 20:971-975.
74. Budd D, Ginsberg H. Hypocholesterolemia and acute myelogenous leukemia: association between disease activity and plasma low density lipoprotein cholesterol concentrations. Cancer 1986; 58:1361-1365.
75. Lindh A, Lindholm M, Rossner S. Intralipid disappearance in critically ill patients. Crit Care Med 1986; 14:476-480.
76. Sun X, Oberlander D, Huang J, et al. Fluid resuscitation, nutritional support, and cholesterol in critically ill postsurgical patients. J Clin Anesth 1998; 10:302-308.
77. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993; 19:933-940.
78. Gordon BR, Parker TS, Levine DM, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996; 24:584-589.
79. Gordon BR, Parker TS, Levine DM, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001; 29:1563-1568.
80. Van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31:1359-1366.
81. Ettinger WH, Varma VK, Sorci-Thomas M, et al. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler Thromb 1994; 14:8-13.
82. Van der Voort PH, Gerritsen RT, Bakker AJ, et al. HDL-cholesterol level and cortisol response to synacthen in critically ill patients. Intensive Care Med 2003; 29:2199-2203.
83. Vishnyakova TG, Bocharov AV, Baranova IN, et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J Biol Chem 2003; 278:22771-22780.
84. Van Leeuwen HJ, Van der Bruggen T, Van Asbeck BS, et al. Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock. Crit Care Med 2001; 29:1074-1077.
85. Den Brinker M, Joosten KF, Liem O, et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90:5110-5117.
86. Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 1999; 27 (Suppl):A33.
87. Oppert M, Schindler R, Husuang C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464.
88. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650.
89. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732.
90. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248.
91. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in patients with early severe ARDS: results of a randomized trial. Chest (in press).
92. Meduri GU, Headley S, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 1998; 280:159-165.
93. Annane D, Sebille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34:22-30.
94. The Acute Respiratory Distress Syndrome Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684. While the results of this study by the Acute Respiratory Distress Syndrome Network group are controversial, this study did demonstrate a reduction in the duration of mechanical ventilation in patients treated with steroids with a trend towards a reduction in mortality in those patients treated prior to day 14.
95. Marik PE, Gayowski T, Starzl TE, et al. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005; 33:1254-1259.
96. Fernandez J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006; 44:1288-1295. This study confirms the observation that adrenal insufficiency is common in patients with advanced liver disease and suggests that the outcome of these patients may be improved with corticosteroid therapy.
97. Eklund A, Leppaniemi A, Kemppainen E, et al. Vasodilatory shock in severe acute pancreatitis without sepsis: is there any place for hydrocortisone treatment? Acta Anaesthesiol Scand 2005; 49:379-384.
98. Huang CJ, Lin HC. Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med 2006; 173:276-280. This well-conducted randomized study explored the role of corticosteroids in patients undergoing weaning from mechanical ventilation.